United States · Funded startup
5 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$86Mraised across 5 rounds since 2007, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by tobiratherapeutics.comSEC filing: $14M sold, first sale Aug 2010
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Jul 2010
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale Mar 2010
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Canaan
Domain Associates
Frazier Healthcare Partners
Montreux Growth PartnersNovo Holdings A/S
Oxford Finance LLCMissing a round, or an investor who was in one? Tell us.
Tobira Therapeutics's investors include Canaan, Domain Associates, Frazier Healthcare Partners, Montreux Growth Partners and Novo Holdings A/S, and 1 more on record.
Tobira Therapeutics has raised $86M across 5 rounds since 2007.
Tobira Therapeutics's most recent round was a Debt of $15M in Jun 2014.
Tobira Therapeutics's largest round on record is $31M (Series B), in Sept 2010.
Tobira Therapeutics's first round on record, in Aug 2007, was backed by Canaan, Domain Associates and Frazier Healthcare Partners and 1 others.
Tobira Therapeutics's latest named round is a Debt, in Jun 2014.
Tobira Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·